Cargando…
Optimising PLGA-PEG Nanoparticle Size and Distribution for Enhanced Drug Targeting to the Inflamed Intestinal Barrier
Oral nanomedicines are being investigated as an innovative strategy for targeted drug delivery to treat inflammatory bowel diseases. Preclinical studies have shown that nanoparticles (NPs) can preferentially penetrate inflamed intestinal tissues, allowing for targeted drug delivery. NP size is a cri...
Autores principales: | Mohan, Lauren J., McDonald, Lauren, Daly, Jacqueline S., Ramtoola, Zebunnissa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699526/ https://www.ncbi.nlm.nih.gov/pubmed/33228175 http://dx.doi.org/10.3390/pharmaceutics12111114 |
Ejemplares similares
-
Effect of Size and Concentration of PLGA-PEG Nanoparticles on Activation and Aggregation of Washed Human Platelets
por: Bakhaidar, Rana, et al.
Publicado: (2019) -
PLGA-PEG Nanoparticles Show Minimal Risks of Interference with Platelet Function of Human Platelet-Rich Plasma
por: Bakhaidar, Rana, et al.
Publicado: (2020) -
Influence of Parathyroid Hormone-Loaded PLGA Nanoparticles in Porous Scaffolds for Bone Regeneration
por: Gentile, Piergiorgio, et al.
Publicado: (2015) -
PEG–PLGA nanoparticles for encapsulating ciprofloxacin
por: Watcharadulyarat, Natsorn, et al.
Publicado: (2023) -
Immunosuppressive Activity of Size-Controlled PEG-PLGA Nanoparticles Containing Encapsulated Cyclosporine A
por: Tang, Li, et al.
Publicado: (2012)